Literature DB >> 11212329

Insights from von Willebrand disease animal models.

C V Denis1, D D Wagner.   

Abstract

von Willebrand disease is a genetic bleeding disorder that arises from abnormalities in von Willebrand factor, an adhesive glycoprotein involved in both primary hemostasis and coagulation. It is the most common inherited bleeding disorder in humans, and over the years several animal species have also been described as suffering from this disease whether through a spontaneous mutation (pigs, dogs) or a genetically engineered one (mouse). These different animal models are extremely useful in exploring the characteristics of von Willebrand disease and in testing new treatments. This review provides an update of the various von Willebrand disease models and the contribution that these models can make to a better understanding of human von Willebrand disease.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 11212329     DOI: 10.1007/s000180050487

Source DB:  PubMed          Journal:  Cell Mol Life Sci        ISSN: 1420-682X            Impact factor:   9.261


  15 in total

1.  Correction of a murine model of von Willebrand disease by gene transfer.

Authors:  Robert G Pergolizzi; Guangchun Jin; Diane Chan; Lorraine Pierre; James Bussel; Barbara Ferris; Philip L Leopold; Ronald G Crystal
Journal:  Blood       Date:  2006-04-25       Impact factor: 22.113

2.  Zebrafish von Willebrand factor.

Authors:  Maira Carrillo; Seongcheol Kim; Surendra Kumar Rajpurohit; Vrinda Kulkarni; Pudur Jagadeeswaran
Journal:  Blood Cells Mol Dis       Date:  2010-10-29       Impact factor: 3.039

Review 3.  Point of care whole blood microfluidics for detecting and managing thrombotic and bleeding risks.

Authors:  Scott L Diamond; Jason M Rossi
Journal:  Lab Chip       Date:  2021-09-28       Impact factor: 7.517

4.  Validation of a von Willebrand factor antigen enzyme-linked immunosorbent assay and newly developed collagen-binding assay.

Authors:  Hilary Burgess; Darren Wood
Journal:  Can J Vet Res       Date:  2008-10       Impact factor: 1.310

5.  Sialyltransferase ST3Gal-IV operates as a dominant modifier of hemostasis by concealing asialoglycoprotein receptor ligands.

Authors:  Lesley G Ellies; David Ditto; Gallia G Levy; Mark Wahrenbrock; David Ginsburg; Ajit Varki; Dzung T Le; Jamey D Marth
Journal:  Proc Natl Acad Sci U S A       Date:  2002-07-03       Impact factor: 11.205

6.  Use of a questionnaire to predict von Willebrand disease status and characterize hemorrhagic signs in a population of dogs and evaluation of a diagnostic profile to predict risk of bleeding.

Authors:  Hilary J Burgess; J Paul Woods; Anthony C G Abrams-Ogg; R Darren Wood
Journal:  Can J Vet Res       Date:  2009-10       Impact factor: 1.310

7.  Evaluation of laboratory methods to improve characterization of dogs with von Willebrand disease.

Authors:  Hilary J Burgess; J Paul Woods; Anthony C G Abrams-Ogg; R Darren Wood
Journal:  Can J Vet Res       Date:  2009-10       Impact factor: 1.310

8.  Congenital Type III von Willebrand's disease unmasked by hypothyroidism in a Shetland sheepdog.

Authors:  Margaret Scuderi; Lauren Bessey; Elisabeth Snead; Hilary Burgess; Anthony Carr
Journal:  Can Vet J       Date:  2015-09       Impact factor: 1.008

9.  ARFI ultrasound monitoring of hemorrhage and hemostasis in vivo in canine von Willebrand disease and hemophilia.

Authors:  Mallory R Scola; Timothy C Nichols; Hongtu Zhu; Melissa C Caughey; Elizabeth P Merricks; Robin A Raymer; Paris Margaritis; Katherine A High; Caterina M Gallippi
Journal:  Ultrasound Med Biol       Date:  2011-10-26       Impact factor: 2.998

Review 10.  Atherosclerosis and thrombosis: insights from large animal models.

Authors:  Gemma Vilahur; Teresa Padro; Lina Badimon
Journal:  J Biomed Biotechnol       Date:  2011-01-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.